Effects of ART Simplification on Inflammatory Markers in CoRis (AIR)

NCT03501719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2025-03-17

No results posted yet for this study

Summary

The effects of the number of drugs included in antiretroviral therapy (ART) regimens of inflammatory markers remains undefined. We will evaluated in participants in the Spanish AIDS Research Network, whether triple ART, dual ART or monotherapy affect differentially the dynamics of inflammatory markers.

Conditions

Interventions

DRUG

Number of drugs in the ART regimen

Triple therapy vs. dual therapy vs. monotherapy

Sponsors & Collaborators

  • Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2022-03-01
Completion
2022-03-01
FDA Drug
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03501719 on ClinicalTrials.gov